Skip to main content
Equibles

PFG Investments, LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1973224 WOODBURY, NY
Back to LCTX Full portfolio

Position in LCTX

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$28,822
-$6,257 QoQ
Shares Held
22,002
-0.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 130 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PFG Investments, LLC holds $9,610,443 across 28 Biotechnology names. LCTX ranks #23 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ADMA
Adma Biologics, Inc.
 270,178 $2,261,389
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,219 $1,102,243
3 BBIO
BridgeBio Pharma, Inc.
 13,125 $977,550
4 ARDX
Ardelyx, Inc.
 137,660 $702,066
5 AUPH
Aurinia Pharmaceuticals Inc.
 30,600 $519,282
6 CRSP
CRISPR Therapeutics AG
 8,587 $468,334
7 NGEN
Nervgen Pharma Corp.
 217,500 $448,050
8 ONC
BeOne Medicines Ltd.
 1,455 $414,631

All Filings in LCTX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,822 22,002
2026-03-31 $35,079 22,202
2025-12-31 $37,077 22,202
2025-09-30 $35,831 21,202
2025-06-30 $19,293 21,202
2025-03-31 $9,540 21,202
2024-12-31 $10,601 21,202
2024-09-30 $19,293 21,202
2024-06-30 $21,202 21,202
2024-03-31 $31,378 21,202
2023-12-31 $22,018 20,200
2023-09-30 $23,836 20,200
2023-06-30 $28,482 20,200
2023-03-31 $30,300 20,200